When used in the treatment of non-psychotic anxiety, compazine prochlorperazine maleate tablets usp should not be administered at doses of more than 20 mg per day or for longer than 12 weeks, because the use of compazine prochlorperazine maleate tablets usp at higher doses or for longer intervals may cause persistent tardive dyskinesia that may […]